Critical Materials
PrivateA single world-class asset (24.99% of Greenbushes) wearing the corpse of a failed nickel-and-refinery empire — re-rated 124% on the lithium-price bounce, now priced for the recovery to keep going while the asset itself springs structural leaks (grade decline + CGP3 fire). Quality mine, broken portfolio, expensive entry. WATCHING.
Research
The verdict
A single world-class asset (24.99% of Greenbushes) wearing the corpse of a failed nickel-and-refinery empire — re-rated 124% on the lithium-price bounce, now priced for the recovery to keep going while the asset itself springs structural leaks (grade decline + CGP3 fire). Quality mine, broken portfolio, expensive entry. WATCHING.
IGO Ltd is a Perth-based ASX-listed mining company that, after a brutal two-year self-reinvention, is now essentially a single-asset lithium royalty wrapped in a winding-down nickel business. Stripped to its economics, IGO is three things stacked on top of each other:
The crown jewel — 24.99% indirect interest in Greenbushes. Through the Tianqi Lithium Energy Australia (TLEA) joint venture, IGO holds an indirect 24.99% economic interest in the Greenbushes Lithium Operation in Western Australia. Greenbushes is the largest and lowest-cost hard-rock lithium mine on Earth, supplying >20% of global high-grade lithium concentrate. The ownership chain: TLEA (Tianqi 51% / IGO 49%) owns 51% of Talison Lithium, which owns Greenbushes; Albemarle owns the other 49% of Talison. Net to IGO: 49% × 51% = 24.99% of the mine's economics. This stake is the overwhelming majority of IGO's intrinsic value.
The albatross — 49% indirect interest in the Kwinana Lithium Hydroxide Refinery. TLEA owns 100% of Kwinana; IGO's 49% of TLEA gives it a 49% indirect interest. Kwinana was meant to capture downstream lithium-chemical margin. Instead it has been a serial loss-maker (FY25 EBITDA loss A$210M on a 100% basis ), is fully impaired on IGO's balance sheet (A$605M write-off), and IGO has publicly stated it sees "no path forward" and is in talks with Tianqi over a full exit.
The wind-down — 100%-owned nickel. The Nova nickel-copper-cobalt mine (Fraser Range, WA) is IGO's only wholly-owned producing operation and reaches end-of-life by late calendar-2026. Forrestania ceased production Sept-2024 and was sold to Medallion Metals for zero cash consideration (Medallion took the plant + rehabilitation liabilities) in March 2026. Cosmos — into which IGO sank A$500M+ — was mothballed (care & maintenance) in June-2024.
How it makes money. IGO's reported revenue is overwhelmingly Nova nickel concentrate sales; the lithium economics flow through equity accounting (its share of TLEA's net profit, plus distributions/dividends from Talison out of free cash flow), not consolidated revenue. This is the single most important structural fact about reading IGO: the asset that matters does not show up in the revenue line — it shows up as "share of profit of associates" and cash distributions. So "IGO revenue" understates the business and "IGO EBITDA" is distorted by the consolidated nickel losses + the unconsolidated lithium profits.
Customers / suppliers / competitors. End customers for spodumene are lithium converters (Tianqi and Albemarle take Greenbushes offtake at the Talison level; pricing now reset more frequently to spot — IGO moved to higher-frequency offtake pricing ). Nova nickel concentrate goes to a small set of offtake counterparties. Suppliers are standard mining inputs (diesel, reagents, mining contractors, power). Competitors as an investable lithium vehicle: Pilbara Minerals (PLS), Mineral Resources (MIN), Liontown (LTR), plus Albemarle and SQM globally (customers.csv empty — n/a in research layer).
Contract structure. No take-or-pay; spodumene priced off a frequently-reset formula tied to lithium chemical prices. The most important "contract" is really the JV governance with Tianqi and Albemarle — IGO is a minority at every level (24.99% of the mine, 49% of TLEA) and therefore does not control its single most valuable asset. That is a structural governance fact, not a footnote.
Named, end-to-end. Spodumene → hydroxide → cathode → cell → EV/ESS.
Upstream inputs → mine. Diesel, grinding media, flotation reagents, electricity (SW Interconnected System, WA), and mining contractors feed the Greenbushes pits. Greenbushes is a hard-rock pegmatite (179Mt reserves at 1.9% Li₂O ).
The asset and its owners.
Midstream — conversion. Greenbushes spodumene (SC6, ~6% Li₂O concentrate) is shipped to converters. Offtake is split between the two JV strategics — Tianqi (China hydroxide/carbonate plants incl. Kwinana) and Albemarle (Kemerton, WA + global). Kwinana itself is the would-be domestic conversion node — and the broken link in the chain.
Downstream — cathode/cell/end-market. Hydroxide → cathode active material (largely China: e.g. major CAM makers) → cell makers (CATL, LG Energy Solution, Panasonic, BYD) → EV OEMs + grid ESS. IGO has no presence below the refinery — its exposure ends at the spodumene/hydroxide gate.
Chokepoints / single-source dependencies.
The moat is the orebody, and it is real — but it is not IGO's moat, it is Greenbushes'. Greenbushes has a genuine, durable cost moat: it is the lowest-cost hard-rock lithium mine globally, posting a 66% EBITDA margin in FY25 and ~75% in the March-2026 quarter even at suppressed spodumene prices. At the trough of the worst lithium bust in a decade, Greenbushes still generated A$1.5B of operating cash flow. That is a first-quartile, arguably first-decile, cost-curve position — the rare mining asset that earns above WACC across the cycle. The moat sources: exceptional grade (1.9% Li₂O reserve grade vs ~1.0–1.3% for most peers), scale, integrated processing, and 40+ years of operating know-how.
But IGO's own moat is thin-to-nonexistent. Strip out Greenbushes and IGO is a sub-scale nickel miner in terminal decline plus a refinery it is trying to give away. The investable question is not "does IGO have a moat" — it's "is owning 24.99% of a great asset, with no control, at a public-market multiple, a good way to own that asset?" That is a structurally weaker proposition than owning the asset outright (which Albemarle and Tianqi effectively do).
Bargaining power.
Switching costs / network effects / IP: none meaningful at the IGO level. The durable advantage is purely the geological endowment of one mine, shared three ways.
segments.csv is empty in the research layer — all figures below are ``, on a 100%-asset basis (i.e. before applying IGO's 24.99%/49% economic share), which is how IGO reports JV-asset performance.
| Segment | FY25 revenue (100% basis) | FY25 EBITDA (100% basis) | Trend | Source |
|---|---|---|---|---|
| Greenbushes (24.99% IGO) | A$1,788M | A$1,173M (66% margin) | Sharp deceleration — FY24 was A$4,638M rev / A$3,953M EBITDA. Revenue −61% YoY on lithium-price collapse | |
| Kwinana refinery (49% IGO) | A$81M | −A$210M (EBITDA loss) | Loss narrowed from −A$356M FY24 but still deeply loss-making; fully impaired | |
| Nova nickel (100% IGO) | n/a (revenue) | FY25 EBITDA distorted; Q4 FY25 underlying EBITDA A$62M | 16,371t Ni + 7,324t Cu + 581t Co @ A$5.53/lb Ni cash cost; end-of-life late-2026 | |
| Forrestania / Cosmos | — | impaired/closed | Forrestania sold for A$0 (Mar-2026); Cosmos C&M (Jun-2024) |
Geography: ~100% Western Australia. No meaningful geographic segmentation.
Group result FY25: net loss after tax A$955M (vs A$3M profit FY24); underlying EBITDA −A$43M (vs +A$581M FY24). The swing from +A$581M to −A$43M underlying EBITDA in one year is the violence of a single-commodity downturn hitting a portfolio with no diversification left.
The read on the trend: Greenbushes decelerated hard but stayed massively profitable; everything else around it bled. The FY25 loss was manufactured by IGO's own non-Greenbushes assets (Kwinana + nickel impairments), not by the crown jewel. The H1 FY26 print confirms the inflection: net loss narrowed 96% to A$34.1M, underlying EBITDA +A$49M, IGO's share of TLEA net loss improved to just −A$1M (from −A$20M), Greenbushes 100%-basis EBITDA A$464M for the half. The business is turning the corner as lithium prices recover.
1H FY26 (reported 19-Feb-2026) — the inflection print:
Most recent quarterly (Mar-2026, Q3 FY26):
vs consensus: no clean consensus beat/miss figure is sourceable — n/a. The market reaction tells the story instead.
Guidance & the tone shift — the critical negative. In April 2026 IGO cut FY26 Greenbushes guidance: spodumene production 1.375–1.425Mt (from 1.5–1.65Mt, −11% midpoint) and unit cash cost A$380–420/t (from A$310–360/t, +~19–25%). Management characterised the problems as "systemic" — safety compliance, feed-grade deterioration, processing recovery rates, and plant reliability all at once. This is the single most important sentence in the whole file: the crown jewel is showing structural, not transitory, operating stress.
Balance-sheet flags: clean. Net cash, negligible debt, A$605M Kwinana impairment already taken (so the bad news is on the page, not hiding). Inventory/receivables not separately sourceable (n/a). The risk is operational/asset, not financial leverage.
Market reaction: two regimes. (1) The structural-problem April-2026 guidance cut triggered an ~18% single-day fall — the worst in over a decade. (2) Yet over the trailing year the stock is up ~124% on the lithium-price recovery. The tape is saying: the macro (lithium price) dominates the micro (Greenbushes operating cracks) — for now.
transcripts/ empty — ``-sourced from call summaries.
Arc of management messaging, FY24 → 1H26:
Recurring phrases: "world-class asset," "lowest-cost hard-rock lithium," "through the cycle," "disciplined capital allocation," "portfolio rationalisation." What they stopped saying: the bullish multi-asset nickel-growth language of the 2021–22 Western Areas era. The word "nickel" has gone from thesis to liability to exit.
Net sentiment read: improving on the macro, but with a fresh and serious crack of candour about the crown jewel's operating health. Management credibility is recovering but not restored — they are still cleaning up the prior team's mess while now having to explain new problems at the one asset that was supposed to be bulletproof.
| Company | Ticker | Mkt cap | EV/EBITDA (1yr fwd) | P/E | Div yield | 5yr avg ROE | Source |
|---|---|---|---|---|---|---|---|
| IGO Ltd | IGO.AX | ~A$6.4B (A$8.5–9.0/sh × 757M) | 2.7x | n/a (loss-making/transitioning) | 0.0% (suspended) | n/a | |
| Pilbara Minerals | PLS.AX | n/a | 6.7x | n/a | n/a | ||
| Mineral Resources | MIN.AX | n/a | 5.5x | n/a | n/a | ||
| Liontown Resources | LTR.AX | n/a | 2.0x | n/a | n/a | ||
| Albemarle | ALB (NYSE) | n/a | n/a | n/a | n/a | not sourced this run | |
| SQM | SQM (NYSE) | n/a | n/a | n/a | n/a | not sourced this run |
Sector context: large-cap ASX lithium is trading ~7–8x EV/EBITDA on FY27 estimates (assuming spodumene rebounds to ~US$1,500/t), compressing to ~6–6.5x by FY28.
The read — and the trap. IGO screens "cheapest" at 2.7x. But that headline multiple is misleading: IGO's reported EBITDA is heavily contaminated by consolidated nickel (which is being wound down to zero) and excludes the equity-accounted Greenbushes profit it actually owns. A clean comparison would value IGO as net cash (~A$300–411M) + 24.99% of Greenbushes' value + 49% of a Kwinana refinery worth ~zero − closure/rehab liabilities − corporate overhead. On a look-through basis IGO is not obviously the cheapest — it is a stub on one asset. Macquarie's framing is the honest one: IGO turns profitable in FY26 with FY27 earnings tripling on the price recovery, which is a statement about lithium-price torque, not about IGO being structurally undervalued versus PLS.
Mostly ``.
What the pattern reveals: IGO trades as a high-beta proxy on the spodumene price, full stop. Idiosyncratic news (M&A, impairments, even a fire at the crown jewel) moves it, but the dominant variable by an order of magnitude is the lithium price. Buy/sell IGO and you are really making a lithium-price call with operating and governance leverage bolted on. The April-2026 fall proved the one exception: when the crown jewel itself is the bad news (not the macro), the market punishes it hard.
CEO — Ivan Vella (appointed Dec-2023, ~2.5yr tenure).
insider-transactions.csv absent). CFO churn is a yellow flag: Kathleen Bozanic → Ian Rowe (interim) → Johan van Vuuren (effective Apr-2026) — three CFO names in short order signals either a deliberate refresh or instability in the finance function.Net: a competent, credible cleanup operator running a company whose prior leadership destroyed substantial capital. The bet on management is a bet that Vella can (a) extract IGO cleanly from Kwinana, (b) close nickel without ugly rehab surprises, and (c) actually fix — or at least manage — the newly-disclosed structural problems at Greenbushes (which are partly outside his control as a 24.99% minority).
financials.csv empty — figures ``; this lens is necessarily lighter than a filing-grounded one. Flagged honestly as such.
Accounting / disclosure risk areas:
Regulatory findings (required sub-section).
total_sec_findings: 0.n/a for specific litigation.Web-only, no financials.csv, no guidance.csv EPS line — so this is a directional `` built from sourced inputs, not a precise bottom-up model. EPS sensitivity to the spodumene price is enormous; I express the projection as scenarios on realised SC6 price, which is the one variable that matters. No forecast.ts create is run (watchlist/unattended rule + the projection is too price-dependent to commit a Brier point honestly).
Anchor facts: 757M shares; net cash ~A$300–411M; FY26 Greenbushes production guidance 1.375–1.425Mt @ A$380–420/t cash cost; IGO's economic share = 24.99%; Nova contributes through ~late-2026 then →0; Kwinana ≈ breakeven-to-loss, treated as zero value; dividend suspended.
| Scenario | Realised SC6 (US$/t) | FY26–28 trajectory | Notes |
|---|---|---|---|
| Bear | ~US$1,000–1,200 (price recovery fades) | Greenbushes EBITDA contribution falls; IGO underlying EPS stays thin/near-breakeven; nickel rolls off late-2026 leaving Greenbushes the only earnings engine | Macquarie's "triple FY27 earnings" evaporates; stock de-rates toward look-through net-cash + a depressed Greenbushes value |
| Base | ~US$1,500 (consensus recovery, holds) | IGO returns to clear profitability in FY26; FY27 earnings ~triple as full-year recovered prices flow through 24.99% of Greenbushes; dividend likely resumes FY27 | The consensus path. Stock at ~2.7x reported / look-through fair-ish |
| Bull | ~US$2,000+ (deficit-driven squeeze; ESS demand) | Greenbushes ~75%-margin economics × 24.99% throw off large distributions; net cash compounds; meaningful capital returns; CGP3 (once de-risked post-fire) adds ~500ktpa capacity | The lithium-bull case; IGO is high-torque equity exposure to it |
Specific EPS figures: n/a (no consensus EPS line obtained; declining to fabricate one). The honest projection statement: IGO's three-year earnings are a leveraged function of the spodumene price × 24.99% of Greenbushes' (now grade-impaired, higher-cost) volumes, plus a net-cash cushion, minus a winding-down nickel business and a ~zero refinery. Base case (US$1,500 SC6) = clear return to profit in FY26 and a ~3x FY27 earnings jump; that is consensus, not contrarian.
Bull case. You are buying 24.99% of the single best hard-rock lithium asset on the planet at a moment when the lithium price has decisively turned (carbonate ~doubled to ~US$26k/t; SC6 to US$1,668/t ) and the company is already debt-free with ~A$300–411M net cash. Greenbushes earns above WACC even at the trough (66% margin, A$1.5B cash flow at the bottom ). The nickel albatross is nearly gone; the Kwinana albatross is fully impaired (downside recognised) and may be exited. If lithium runs to deficit on ESS + EV demand, IGO is high-torque, balance-sheet-safe exposure with FY27 earnings tripling and a probable dividend resumption. The market has re-rated it 124% and it can still work if the cycle has legs.
Bear case (the permanent-impairment risks).
Pre-mortem (18 months out, thesis broke — what happened?): Lithium rolled over again (Chinese lepidolite + African supply + slowing EV growth overwhelmed ESS demand); SC6 fell back toward US$1,000. Simultaneously Greenbushes' "systemic" problems proved persistent — grade decline + post-fire CGP3 delays kept volumes low and unit costs high — so IGO got the worst of both: a falling price on shrinking, costlier volumes. Nickel closure threw up rehab cost surprises. The 124% re-rate unwound and IGO round-tripped back toward A$4–5.
Are multiples too high? Headline 2.7x EV/EBITDA looks cheap but is contaminated (Lens 7). On a clean look-through, after the 124% run, IGO is fairly-to-fully valued for the base case — it is not cheap optionality anymore; it is a consensus lithium-recovery long with asset-specific cracks.
Contrarian view (what the market is refusing to see): The market is treating IGO as a clean leveraged lithium proxy and rewarding it accordingly — but it is quietly ignoring that the crown jewel itself just told you its problems are structural, not cyclical. The bull narrative ("world-class lowest-cost asset, buy the cycle") is fighting a slow, permanent erosion of the very cost advantage that defines the asset. The April-2026 18% one-day fall was the market briefly seeing it, then forgetting again as the lithium price spiked on the fire. Greenbushes getting more expensive to run is the under-priced risk.
Dismantling the bull case as a skeptical short.
A self-help margin re-rating priced as a doomed smelter — the $0 TC/RC tape masks that Aurubis already earns more from downstream premiums, recycling and a finished $1.7B capex cycle than from the concentrate spread the bears fixate on; watching, not yet a buy, because the metal-price tailwind that lifted FY25/26 guidance twice is the same lever that breaks on a copper pullback.
A 38-year, $1.7B-NPV NdPr asset that the equity market is pricing as a serial dilution machine — the call is on financing-close + China's price floor, not the ore body. WATCHING into FID-completion; the project is fundable, the share count is the bear case.
A best-in-class, Luksic-controlled Chilean copper pure-play priced for the 30% volume ramp it has not yet delivered — own the asset, not this multiple; the entry is a copper-price dip or a Centinela-2 commissioning wobble, not 14x EV/EBITDA on a name that just missed guidance again.